The Tisch Cancer Institute, a National Cancer Institute-designated cancer center, employs a multidisciplinary approach to cancer research and treatment, with the goal of advancing clinical breakthroughs that help prevent and eradicate cancer. Read the 2020 Specialty Report online for articles on:
• Novel In Situ Cancer Vaccine Shows Promising Results in Patients With Indolent B Cell Lymphoma
• Myeloma Drug Helps Patients With Few Treatment Options
• Optimal Dosing for Head and Neck Squamous Cell Cancer
• Therapies That Control Myeloproliferative Neoplasms
• Innovative Barcoding Technology Allows Scientists to Characterize the Biologic Effects of Genes
• Single-Cell Technology Provides a Close-Up View of How Immune Therapies Change the Microenvironment of Tumors
• Making Headway Against the Elusive RAS Oncogene
• Unmasking the Oncogene That Could Lead to New Therapies for Liver Cancer